Clinical Trial Update: Linerixibat Long-term Safety, and Tolerability Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating long-term safety and tolerability of linerixibat in cholestasis; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholestasis

Drugs mentioned

• Linerixibat (linerixibat)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cholestasis | Phase 3 | Status: ACTIVE_NOT_RECRUITING